CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SCANnTREAT aims to enhance cancer treatment by integrating advanced imaging and therapy technologies. It utilizes a spectral photon counting scanner for precise diagnostics and a new X-ray-based therapy to improve patient outcomes with minimal side effects, all performed simultaneously to reduce patient stress.
According to Eurostat, cancer accounts for the second cause of death in Europe.
We are aiming at a breakthrough technology that will contribute to increase drastically patients five years survival and have significant positive impact on their quality of life.
Such ambition will be reached thanks to a new future technology that will ensure the efficient treatment of cancer with low side-effects (even if radioresistant), allow to perform accurate diagnostic and give access to in situ monitoring of…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Maastricht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
PHILIPS MEDICAL SYSTEMS TECHNOLOGIES LTD
Israel, Haifa
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
